Abstract | BACKGROUND: Morbidity and mortality from oral cancer is still considerable, and has not improved significantly over the last four or five decades. Early preventive intervention in persons at high risk may improve treatment results. MATERIAL AND METHODS: RESULTS: INTERPRETATION:
|
Authors | Jon Sudbø |
Journal | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
(Tidsskr Nor Laegeforen)
Vol. 123
Issue 11
Pg. 1518-21
(May 29 2003)
ISSN: 0807-7096 [Electronic] Norway |
Vernacular Title | Kjemoprevensjon av munnhulekreft. |
PMID | 12822012
(Publication Type: Journal Article, Review, Retracted Publication)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Anticarcinogenic Agents
- Cyclooxygenase Inhibitors
- Retinoids
- ErbB Receptors
|
Topics |
- Anti-Inflammatory Agents, Non-Steroidal
(administration & dosage)
- Anticarcinogenic Agents
(administration & dosage)
- Chemoprevention
(methods)
- Cyclooxygenase Inhibitors
(administration & dosage)
- ErbB Receptors
(antagonists & inhibitors, drug effects)
- Genetic Predisposition to Disease
- Humans
- Leukoplakia, Oral
(pathology, prevention & control)
- Mouth Neoplasms
(genetics, pathology, prevention & control)
- Retinoids
(administration & dosage)
- Risk Factors
|